These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37728881)

  • 1. Assessing and improving the quality of guideline-adherent hepatitis B virus care in people with HIV: A cross-sectional study.
    Oomen PG; van Kraaij VJ; Gerritsma AM; Verduyn Lunel FM; Boland GJ; Hoepelman AI; van Welzen BJ
    Int J STD AIDS; 2024 Oct; 35(11):910-915. PubMed ID: 37728881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term observation on hepatitis B surface antigen seroclearance in therapy experienced HIV/HBV co-infected Chinese.
    Yang R; Gui X; Ke H; Xiong Y; Gao S
    J Viral Hepat; 2020 Feb; 27(2):127-134. PubMed ID: 31571343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of hepatitis delta virus among people with hepatitis B virus and HIV coinfection in Botswana.
    Baruti K; Phinius BB; Phakedi B; Mpebe G; Choga W; Bhebhe L; Mulenga G; Moraka NO; Ratsoma T; Pretorius-Holme M; Makhema J; Shapiro R; Lockman S; Moyo S; Jongman M; Anderson M; Gaseitsiwe S
    J Infect Public Health; 2023 Nov; 16(11):1736-1741. PubMed ID: 37734129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study.
    Hønge BL; Jespersen S; Medina C; Té Dda S; da Silva ZJ; Lewin S; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Krarup H;
    PLoS One; 2014; 9(6):e99971. PubMed ID: 24915064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
    Boyd A; Maylin S; Moh R; Mahjoub N; Gabillard D; Eholié SP; Danel C; Anglaret X; Zoulim F; Girard PM; Delaugerre C; Lacombefor K;
    J Gastroenterol Hepatol; 2016 Mar; 31(3):634-44. PubMed ID: 26313291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?
    Sheldon J; Ramos B; Toro C; Ríos P; Martínez-Alarcón J; Bottecchia M; Romero M; Garcia-Samaniego J; Soriano V
    Antivir Ther; 2008; 13(1):97-102. PubMed ID: 18389903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence, risk factors and genotypes of hepatitis B infection among HIV-infected patients in the State of MS, Central Brazil.
    Freitas SZ; Soares CC; Tanaka TS; Lindenberg AS; Teles SA; Torres MS; Mello FC; Mendes-Corrêa MC; Savassi-Ribas F; Motta-Castro AR
    Braz J Infect Dis; 2014; 18(5):473-80. PubMed ID: 24662138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus seromarkers among HIV infected adults on ART: An unmet need for HBV screening in eastern Ethiopia.
    Ayana DA; Mulu A; Mihret A; Seyoum B; Aseffa A; Howe R
    PLoS One; 2019; 14(12):e0226922. PubMed ID: 31887187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
    Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
    AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Hepatitis B and Liver Outcomes Among Adults Taking Tenofovir-Containing Antiretroviral Therapy for HBV/HIV Coinfection in Zambia.
    Vinikoor MJ; Hamusonde K; Muula G; Asombang M; Riebensahm C; Chitundu H; Sunkuntu-Sichizya V; Bhattacharya D; Sinkala E; Lauer G; Chung R; Mbewe W; Egger M; Bosomprah S; Wandeler G
    Clin Infect Dis; 2024 Jun; 78(6):1583-1590. PubMed ID: 37997691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and viral suppression of hepatitis B virus infection among people living with HIV on antiretroviral therapy in Sierra Leone.
    Song JW; Lakoh S; Chen SY; Jalloh MB; Sevalie S; Baldeh M; Nyambe MK; Nicholas VD; Yendewa G; Wang FS; Yang G
    Sex Transm Infect; 2024 Jul; 100(5):264-270. PubMed ID: 38789266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype.
    Madejón A; Romero M; Hernández Á; García-Sánchez A; Sánchez-Carrillo M; Olveira A; García-Samaniego J
    World J Gastroenterol; 2016 Mar; 22(11):3165-74. PubMed ID: 27003993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low sero-prevalence of hepatitis delta antibodies in HIV/ hepatitis B co-infected patients attending an urban HIV clinic in Uganda.
    Katwesigye E; Seremba E; Semitala F; Ocama P
    Afr Health Sci; 2017 Dec; 17(4):974-978. PubMed ID: 29937867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of occult hepatitis B infection among treatment-naive persons living with HIV in Ghana.
    Salia E; Nartey YA; Djankpa FT; Pappoe F; Nuvor SV; Obiri-Yeboah D
    PLoS One; 2024; 19(6):e0305862. PubMed ID: 38924017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognizing the impact of endemic hepatitis D virus on hepatitis B virus eradication.
    Goyal A; Murray JM
    Theor Popul Biol; 2016 Dec; 112():60-69. PubMed ID: 27594346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China.
    He Y; Lin W; Li H; Gu F; Zhong H; Lan Y; Li Y; Guo P; Hu F; Cai W; Tang X; Li L
    Chin Med J (Engl); 2023 Nov; 136(22):2686-2693. PubMed ID: 37881959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates and determinants of hepatitis B 'e' antigen and hepatitis B surface antigen seroclearance during long-term follow-up of patients coinfected with HIV and hepatitis B virus.
    Boyd A; Gozlan J; Miailhes P; Lascoux-Combe C; Cam MS; Rougier H; Zoulim F; Girard PM; Lacombe K
    AIDS; 2015 Sep; 29(15):1963-73. PubMed ID: 26153669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult hepatitis B virus infection in a cohort of HIV-positive patients: correlation with hepatitis C virus coinfection, virological and immunological features.
    Morsica G; Ancarani F; Bagaglio S; Maracci M; Cicconi P; Cozzi Lepri A; Antonucci G; Bruno R; Santantonio T; Tacconi L; Baldelli F; Piscopo R; Santoro D; Lazzarin A; D'Arminio Monforte A;
    Infection; 2009 Oct; 37(5):445-9. PubMed ID: 19669092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence and characteristics of hepatitis B and D virus infections among HIV-positive individuals in Southwestern Nigeria.
    Opaleye OO; Akanbi OA; Osundare FA; Wang B; Adesina O; Oluremi AS; Sunday ST; Akindele AA; Klink P; Bock CT
    Virol J; 2021 Jan; 18(1):20. PubMed ID: 33446224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.
    Boyd A; Moh R; Maylin S; Abdou Chekaraou M; Mahjoub N; Gabillard D; Anglaret X; Eholié SP; Delaugerre C; Danel C; Zoulim F; Lacombe K;
    J Viral Hepat; 2018 Oct; 25(10):1121-1131. PubMed ID: 29660214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.